Alzheimer’s Disease affects 5.3M individuals in the US and 35M worldwide according to the Alzheimer’s Association. As the overall population ages, the number of cases will grow rapidly. An effective treatment for this devastating disease is needed.
We believe such a treatment has been discovered. ADispell has licensed the rights to commercialize novel technology that has exciting promise as potential drug products that halt, and perhaps reverse, the brain deterioration caused by Alzheimer’s Disease. Find out more.